Journal ArticleOPEN ACCESS

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials

European Heart Journal (2024) 45(15) 1371-1374
DOI: 10.1093/eurheartj/ehae028
12Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Mellbin, L. G., Bhatt, D. L., David, J. P., Ekström, K., Petrie, M. C., Rasmussen, S., & Vilsbøll, T. (2024). Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials. European Heart Journal, 45(15), 1371–1374. https://doi.org/10.1093/eurheartj/ehae028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free